AHO, V., GEBHARDT, C., LEIST, A., KLEE, M., PAVELKA, L., & WILMES, P. (2024). Behind the paper: Gut microbes and mild cognitive impairment in Parkinson’s disease — is there a connection? ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/61627. |
  | AHO, V., KLEE, M., LANDOULSI, Z., Heintz-Buschart, A., PAVELKA, L., LEIST, A., KRÜGER, R., MAY, P., WILMES, P., & NCER-PD Consortium. (06 April 2024). Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease. NPJ Parkinson's Disease, 10 (1), 78. doi:10.1038/s41531-024-00687-1  Peer Reviewed verified by ORBi |
 | KLEE, M., AHO, V., MAY, P., Heintz-Buschart, A., LANDOULSI, Z., JONSDOTTIR, S., PAULY, C., PAVELKA, L., DELACOUR, L., KAYSEN, A., Krüger, R., WILMES, P., LEIST, A., Acharya, G., Aguayo, G., Alexandre, M., ALI, M., Ammerlann, W., ARENA, G., ... ZELIMKHANOV, G. (2024). Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome. Journal of Prevention of Alzheimer's Disease. doi:10.14283/jpad.2024.19 Peer reviewed |
  | KLEE, M., AHO, V., MAY, P., KRÜGER, R., WILMES, P., & LEIST, A. (2023). EDUCATION AS A RISK FACTOR OF MILD COGNITIVE IMPAIRMENT—THE ROLE OF THE GUT MICROBIOME. Innovation in Aging. doi:10.1093/geroni/igad104.0228 Peer Reviewed verified by ORBi |
KLEE, M., AHO, V., MAY, P., Heintz-Buschart, A., LANDOULSI, Z., JONSDOTTIR, S., PAULY, C., PAVELKA, L., DELACOUR, L., KAYSEN, A., KRÜGER, R., WILMES, P., LEIST, A., & NCER-PD Consortium. (November 2023). Education as risk factor of Mild Cognitive Impairment - the role of the gut microbiome. Presentation in symposium: Social determinants of brain health: From the search for mechanisms to recommendations to increase equity [Paper presentation]. Annual Meeting of the Gerontological Society of America. |
 | AHO, V., KLEE, M., LANDOULSI, Z., Heintz-Buschart, A., PAVELKA, L., LEIST, A.* , Krüger, R.* , MAY, P.* , & WILMES, P.*. (2023). Mild cognitive impairment is not associated with gut microbiota alterations in Parkinson’s disease. (v1). ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57437. doi:10.21203/rs.3.rs-3372525/v1 * These authors have contributed equally to this work. |
 | SCHMIT, K.* , GARCIA, P.* , SCIORTINO, A., AHO, V., Pardo Rodriguez, B., THOMAS, M., GERARDY, J.-J., Bastero Acha, I., HALDER, R., CIALINI, C., HEURTAUX, T., Ostahi, I., BUSI, S. B., Grandmougin, L., LOWNDES, T., Singh, Y., Martens, E. C., MITTELBRONN, M., BUTTINI, M.* , & WILMES, P. (26 September 2023). Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease. Cell Reports, 42 (9), 113071. doi:10.1016/j.celrep.2023.113071 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | HANSEN, B., LACZNY, C. C., AHO, V., Frachet-Bour, A., Habier, J., OSTASZEWSKI, M., Michalsen, A., Hanslian, E., Koppold, D. A., Hartmann, A. M., Steckhan, N., Mollenhauer, B., Schade, S., RUMP, K., SCHNEIDER, J., & WILMES, P. (18 August 2023). Protocol for a multicentre cross-sectional, longitudinal ambulatory clinical trial in rheumatoid arthritis and Parkinson's disease patients analysing the relation between the gut microbiome, fasting and immune status in Germany (ExpoBiome). BMJ Open, 13 (8), 071380. doi:10.1136/bmjopen-2022-071380 Peer Reviewed verified by ORBi |
KLEE, M., AHO, V., MAY, P., Heintz-Buschart, A., LANDOULSI, Z., JONSDOTTIR, S., PAULY, C., PAVELKA, L., DELACOUR, L., KAYSEN, A., KRÜGER, R., WILMES, P., LEIST, A., & NCER-PD Consortium, (Other coll.). (July 2023). Education as risk factor of Mild Cognitive Impairment - the role of the gut microbiome [Poster presentation]. Alzheimer’s Association (AAIC) Conference. |
KLEE, M., AHO, V., MAY, P., KRÜGER, R., WILMES, P., LEIST, A., & NCER-PD Consortium (Other coll.). (January 2023). Education as risk factor of Mild Cognitive Impairment - the role of the gut microbiome [Poster presentation]. Conference Precision Medicine in Parkinson’s: Past lessons and conquering new frontiers. |
 | AHO, V., OSTASZEWSKI, M., Martin-Gallausiaux, C., LACZNY, C. C., SCHNEIDER, J., & WILMES, P. (14 September 2022). SnapShot: The Expobiome Map. Cell Host and Microbe, 30 (9), 1340. doi:10.1016/j.chom.2022.08.015 Peer Reviewed verified by ORBi |
 | WILMES, P., Martin-Gallausiaux, C., OSTASZEWSKI, M., AHO, V., NOVIKOVA, P., LACZNY, C. C., & SCHNEIDER, J. (14 September 2022). The gut microbiome molecular complex in human health and disease. Cell Host and Microbe, 30 (9), 1201-1206. doi:10.1016/j.chom.2022.08.016 Peer Reviewed verified by ORBi |
 | TALAVERA ANDUJAR, B., AURICH, D., AHO, V., Singh, R. R., Cheng, T., Zaslavsky, L., Bolton, E. E., Mollenhauer, B., WILMES, P., & SCHYMANSKI, E. (2022). Studying the Parkinson's disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot study. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-022-04207-z Peer Reviewed verified by ORBi |
 | Trezzi, J.-P., AHO, V., Jäger, C., Schade, S., Janzen, A., HICKL, O., Kunath, B., THOMAS, M., SCHMIT, K., GARCIA, P., SCIORTINO, A., Martin-Gallausiaux, C., HALDER, R., Huarte, O. U., HEURTAUX, T., Heins-Marroquin, U., Gomez-Giro, G., Weidenbach, K., DELACOUR, L., ... WILMES, P. (2022). An archaeal compound as a driver of Parkinson’s disease pathogenesis. (1). ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/51987. doi:10.21203/rs.3.rs-1827631/v1 |
 | Heinzel, S., AHO, V., Suenkel, U., von Thaler, A.-K., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., Maetzler, W., Berg, D., Auvinen, P., & Scheperjans, F. (2020). Gut microbiome signatures of risk and prodromal markers of Parkinson's disease. Annals of Neurology. doi:10.1002/ana.25788 Peer Reviewed verified by ORBi |
 | Boertien, J. M., Pereira, P. A. B., AHO, V., & Scheperjans, F. (October 2019). Increasing comparability and utility of gut microbiome studies in Parkinson's disease: A systematic review. Journal of Parkinson's Disease, 9 (s2), 297-S312. doi:10.3233/JPD-191711 Peer Reviewed verified by ORBi |
 | AHO, V., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019). Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine, 44, 691–707. doi:10.1016/j.ebiom.2019.05.064 Peer Reviewed verified by ORBi |
 | Hasan, S., AHO, V., Pereira, P. A. B., Paulin, L., Koivusalo, S. B., Auvinen, P., & Eriksson, J. G. (2018). Gut microbiome in gestational diabetes: a cross-sectional study of mothers and offspring 5 years postpartum. Acta Obstetricia et Gynecologica Scandinavica, 97 (1), 38-46. doi:10.1111/aogs.13252 Peer Reviewed verified by ORBi |
 | Kelhälä, H.-L., AHO, V., Fyhrquist, N., Pereira, P. A. B., Kubin, M. E., Paulin, L., Palatsi, R., Auvinen, P., Tasanen, K., & Lauerma, A. (2018). Isotretinoin and lymecycline treatments modify the skin microbiota in acne. Experimental Dermatology, 27 (1), 30-36. doi:10.1111/exd.13397 Peer Reviewed verified by ORBi |
 | Pereira, P. A. B., AHO, V., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2017). Oral and nasal microbiota in Parkinson's disease. Parkinsonism and Related Disorders, 38, 61-67. doi:10.1016/j.parkreldis.2017.02.026 Peer Reviewed verified by ORBi |
 | Mertsalmi, T. H., AHO, V., Pereira, P. A. B., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2017). More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota. European Journal of Neurology, 24 (11), 1375-1383. doi:10.1111/ene.13398 Peer Reviewed verified by ORBi |
 | Salava, A., AHO, V., Lybeck, E., Pereira, P., Paulin, L., Nupponen, I., Ranki, A., Auvinen, P., Andersson, S., & Lauerma, A. (2017). Loss of cutaneous microbial diversity during first 3 weeks of life in very low birthweight infants. Experimental Dermatology, 26 (10), 861-867. doi:10.1111/exd.13312 Peer Reviewed verified by ORBi |
 | Salava, A., Pereira, P., AHO, V., Vakeva, L., Paulin, L., Auvinen, P., Ranki, A., & Lauerma, A. (2017). Skin microbiome in small- and large-plaque parapsoriasis. Acta Dermato Venereologica, 97 (6), 685-691. doi:10.2340/00015555-2631 Peer Reviewed verified by ORBi |
 | Pereira, P., AHO, V., Arola, J., Boyd, S., Jokelainen, K., Paulin, L., Auvinen, P., & Farkkila, M. (2017). Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia. PLoS ONE, 12 (8), 0182924. doi:10.1371/journal.pone.0182924 Peer Reviewed verified by ORBi |
 | Salava, A., AHO, V., Pereira, P., Koskinen, K., Paulin, L., Auvinen, P., & Lauerma, A. (2016). Skin microbiome in melanomas and melanocytic nevi. European Journal of Dermatology, 26 (1), 49-55. doi:10.1684/ejd.2015.2696 Peer Reviewed verified by ORBi |
 | Scheperjans, F., AHO, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola-Rautio, J., Pohja, M., Kinnunen, E., Murros, K., & Auvinen, P. (2015). Gut microbiota are related to Parkinson's disease and clinical phenotype. Movement Disorders, 30 (3), 350-358. doi:10.1002/mds.26069 Peer Reviewed verified by ORBi |
 | AHO, V., Pereira, P. A. B., Haahtela, T., Pawankar, R., Auvinen, P., & Koskinen, K. (2015). The microbiome of the human lower airways: a next generation sequencing perspective. World Allergy Organization Journal, 8 (1), 23-015-0074. doi:10.1186/s40413-015-0074-z Peer Reviewed verified by ORBi |